You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

News provided by

U.S. Food and Drug Administration

Jan 15, 2019, 12:19 ET